Go to Client Portal
NAMSA

Biological and Clinical Evaluations Conference for Medical Devices

About

Date/Time

Date(s) - October 5, 2021 - October 6, 2021

Location

Sankt Gertrud Conference
Östergatan
Malmö, 7B 211 25

NAMSA invites you to join us at the Biological and Clinical Evaluations Conference for Medical Devices on October 5-6 in Sweden. An international conference on medical device pre- and post-market strategies for biological evaluation, material characterization and clinical evaluation and investigations. Don’t miss this unique opportunity to broaden your understanding and expand your professional network, in addition to learning the latest news within biocompatibility, clinical evaluations and investigations.

COMPLIMENTARY CONSULTATIONS
Visit us for complimentary 30-minute consultations with NAMSA’s experts throughout the event. We welcome the opportunity to discuss with you the most cost-effective pathways to market based on your unique product development requirements.

Please email us at communications@namsa.com to reserve your consultation time, or simply stop by the booth in the exhibitor area to meet with us. We hope to see you there!

NAMSA Session

Session 4 on October 5

Methods for Biological Evaluation of Drug-device Combination Products

Speaker

Gaelle Clermont

Product Development Strategist

Gaelle has over 15 years’ experience within the medical device industry, and has directed numerous preclinical studies in many fields, most notably cardiology, orthopedics, gastroenterology, dental, wound healing, general surgery, and drug delivery. Gaëlle has supported the development and regulatory approval of various devices, combination products and new biotechnologies through preclinical safety, performance and efficacy evaluations. She is an industry-leading expert in assisting global device manufacturers to accelerate clinical research and regulatory approval of innovative medical technologies.

Gaëlle holds a Doctorate in Pharmaceutical Sciences Degree and PhD in Cardiovascular Pharmacology from the University of Burgundy (France). She also earned a Medical Device and Biological Products Regulation Degree from the University of Paris.